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Abstract: Bioassay-guided fractionation of an EtOAc extract of the broth of the endophytic fungus
Nemania sp. UM10M (Xylariaceae) isolated from a diseased Torreya taxifolia leaf afforded three known
cytochalasins, 19,20-epoxycytochalasins C (1) and D (2), and 18-deoxy-19,20-epoxy-cytochalasin C
(3). All three compounds showed potent in vitro antiplasmodial activity and phytotoxicity with no
cytotoxicity to Vero cells. These compounds exhibited moderate to weak cytotoxicity to some of the
cell lines of a panel of solid tumor (SK-MEL, KB, BT-549, and SK-OV-3) and kidney epithelial cells
(LLC-PK11 ). Evaluation of in vivo antimalarial activity of 19,20-epoxycytochalasin C (1) in a mouse
model at 100 mg/kg dose showed that this compound had weak suppressive antiplasmodial activity
and was toxic to animals.
Keywords: Nemania; Xylariaceae; Torreya taxifolia; plant pathogenic and endophytic fungi; cytochalasins;
malaria; cytotoxicity; phytotoxicity

1. Introduction
Malaria remains a serious threat to human health in many parts of the tropics and subtropics,
and an estimated 216 million cases and 445,000 deaths occurred worldwide in 2016 [1]. This disease is
caused by apicomplexan parasites of the genus Plasmodium. P. falciparum, which is responsible for the
majority of malaria deaths, has developed resistance to all currently available drugs, and mosquito
vectors have become resistant to one or more insecticides in all WHO regions [1]. There is an urgent
need to develop novel drugs with new modes of action for effective control of this disease.
Apicomplexan parasites such as Plasmodia contain the apicoplast organelle that is similar to
plastids found in the cells of photosynthetic organisms with the same genetic complements [2].
Apicoplasts have some essential plant-like metabolic pathways which are absent in mammalian hosts.
Over the last decade, a number of validated targets in plant-like metabolic pathways in the apicoplast
of malaria parasites have been reported [3–7]. Apicoplasts perform vital metabolic functions and are
essential for both erythrocytic and hepatic development of the parasites in mammalian hosts [3–7].
Molecules 2019, 24, 777; doi:10.3390/molecules24040777
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Therefore, plant-like metabolic pathways in apicoplasts serve as promising targets for antimalarial
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2. Results and Discussion
An EtOAc extract of the fermentation broth of the endophytic fungus isolated from a diseased
An EtOAc extract of the fermentation broth of the endophytic fungus isolated from a diseased
T. taxifolia leaf showed good phytotoxic activity against both a dicot (lettuce, Lactuca sativa L.) and a
T. taxifolia leaf showed good phytotoxic activity against both a dicot (lettuce, Lactuca sativa L.) and a
monocot (bentgrass, Agrostis stolonifera L.) and potent antiplasmodial activity against
monocot (bentgrass, Agrostis stolonifera L.) and potent antiplasmodial activity against chloroquine-sensitive
chloroquine-sensitive (D6) and -resistant (W2) strains of P. falciparum (IC50 = 40 and 44 ng/mL
(D6) and -resistant (W2) strains of P. falciparum (IC50 = 40 and 44 ng/mL respectively) with low
respectively) with low cytotoxicity (6800 ng/mL) to mammalian kidney fibroblasts (Vero cells).
cytotoxicity (6800 ng/mL) to mammalian kidney fibroblasts (Vero cells).
Analysis of the ITS genomic region (partial 18S ribosomal RNA gene, internal transcribed
Analysis of the ITS genomic region (partial 18S ribosomal RNA gene, internal transcribed spacer
spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, and partial 28S ribosomal
1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, and partial 28S ribosomal RNA gene)
RNA gene) of this fungus (Figure 4 and Supplementary, Table S1) indicated that it is related to the
of this fungus (Figure 4 and Supplementary, Table S1) indicated that it is related to the genus Nemania
genus Nemania of the family Xylariaceae with 545 of 557 nucleotides (98% sequence identity) to the
of the family Xylariaceae with 545 of 557 nucleotides (98% sequence identity) to the Nemania sp.
Nemania sp. genotype 547 isolate NC0453 (GenBank accession: JQ761479.1) which represents an
genotype 547 isolate NC0453 (GenBank accession: JQ761479.1) which represents an endolichenic
endolichenic fungus of the host Pseudevernia consocians. Since it does not show a 100% identity to
fungus of the host Pseudevernia consocians. Since it does not show a 100% identity to other already
other already published Nemania species in GenBank, this fungus was designated as a new isolate,
published Nemania species in GenBank, this fungus was designated as a new isolate, UM10M (GenBank
UM10M (GenBank accession: MK321315).
accession: MK321315).
The EtOAc extract of the culture broth of Nemania sp. UM10M was fractionated over silica gel
and subsequently separated over Sephadex LH-20 and PTLC to afford three compounds. Compound 1
was identified as 19,20-epoxycytochalasin C by spectroscopic methods. This compound has previously
been reported from several Xylaria species [24–26] and an unidentified endophytic fungus [27]. Our 1 H
and 13 C NMR assignments were comparable to reported data, but the chemical shift for H-11 needs to
be revised, and the 13 C assignments for C-11 and C-12, and C-13 and C-14 need to be interchanged [25]
(Table 1). Compound 2 has been isolated from Xylaria [25,28] Engleromyces [29,30], and an unidentified
endophytic fungus [27], and its NMR data were comparable to the reported data [30].
Compound 3 (18-deoxy-19,20-epoxycytochalasin C) has been reported from an unidentified
endophytic fungus, KL-1.1, and isolated from Psidium guajava leaves [27]. However, in the structure
drawn for this compound, the absolute configurations of C-4 (R) and C-19 (S) were not correctly
represented [30]. The NMR data for compound 3 were comparable to the reported data but the 13 C
assignments for C-12 and C-23 need to be interchanged (Table 1).
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presumably share the same biosynthetic precursor, they all possess the same absolute configuration.
Therefore the structures and absolute configurations of these compounds were determined
as (3S,4R,7S,8S,9R,16S,18R,19R,20S,21S)-19,20-epoxycytochalasin C (1), (3S,4R,5S,7S,8S,9R,16S,18R,
19R,20S,21S)-19,20-epoxycytochalasin D (2), and (3S,4R,7S,8S,9R,16(S),18S,19S,20R,21S)-18-deoxy19,20-epoxycytochalasin C (3) and are correctly represented in the structures shown in Figure 3.
Table 1. 1 H and 13 C NMR data of 1 and 3 in CDCl3 -methanol-d4 .
1

Carbon
δC
1
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
10
0
2 ,60
30 ,50
40
a 1H

b

175.0
61.0
49.9
126.4
131.8
68.1
48.7
52.0
44.1
16.7
13.8
131.4
132.9
37.5
41.7
215.3
76.3
59.9
53.2
72.0
18.9
21.5
170.4
20.5
137.3
129.2
128.6
126.8

3
δH a (J in Hz)
3.35, t (7.3)
2.50, brs

3.76, brd (9.9)
2.25, dd (10.1,10.0)
3.03, d (7.4)
1.19, s
1.62, s
5.99, dd (15.5, 10.2)
5.68, ddd (15.6, 9.7, 5.8)
2.63, dd (22.7, 11.9), 2.14, m c
3.27, m c
3.25, brs c
3.38, brs
5.75, s
1.21, d (7.6)
1.54, s
2.18, s
7.28, m
7.33, m
7.25, m

δC

b

175.1
61.1
49.9
128.5
131.7
68.1
49.0
51.8
44.4
14.1
13.9
131.0
133.7
37.6
42.9
216.9
52.1
58.6
57.6
72.3
18.8
17.1
170.5
20.7
136.9
129.4
128.7
126.9

δH

a

(J in Hz)

3.32, m
2.43, brs

3.77, d (9.7)
2.27, dd, (10.1, 10.1)
3.04, bd, (7.5)
1.26, s
1.65, s
6.24, dd (15.5, 10.4)
5.61, m
2.53, dd (25.3, 12.2), 2.14 m c
2.98, d (1.8)
2.18, m c
3.01, m c
3.38, d (1.7)
5.69, s
1.12, d (6.7)
1.32, d (6.9)
2.15, s
7.26, m
7.33, m
7.25, m

NMR spectra recorded at 400 MHz, b 13 C NMR spectra recorded at 100 MHz, c overlapped signal.

Compounds 1–3 showed potent selective (calculated as a ratio of IC50 for cytotoxicity to Vero
cells and IC50 for antimalarial activity) in vitro antiplasmodial activity against chloroquine-sensitive
(D6) and -resistant (W2) strains of P. falciparum (Table 2) and nonspecific moderate phytotoxic activity
against both a monocot (bentgrass, Agrostis stolonifera) and a dicot (lettuce, Lactuca sativa cv. L., iceberg)
in the presence of light (Table 3).
Table 2. Antiplasmodial activity of 1–3.

Compound

19,20-Epoxycytochalasin C (1)
19,20-Epoxycytochalasin D (2)
18-Deoxy-19,20-epoxy-cytochalasin C (3)
Chloroquine a
Artemisinin a
a

Chloroquine-Sensitive
(D6)-Strain

Chloroquine-Resistant
(W2)-Strain

Cytotoxicity to
Vero Cells

IC50 µM
(ng/mL)

S. I.

IC50 µM
(ng/mL)

S. I.

IC50 µM

0.07 (37)
0.04 (22)
0.56 (280)
0.03 (16)
0.02 (5.6)

>128.6
>216.3
>17
>297.5
>850

0.05 (28)
0.04 (20)
0.19 (100)
0.31 (160)
0.01 (3.0)

>170
>238
>47.6
>29.8
>1586.6

NC
NC
NC
NC
NC

Positive controls; NC: not cytotoxic at the highest concentration tested (4760 ng/mL); S. I. (selectivity index) = IC50
for cytotoxicity/IC50 for antiplasmodial activity.

Molecules 2019, 24, 777

6 of 12

Table 3. Phytotoxic activity of 1–3 a .
Compound
19,20-Epoxycytochalasin C (1)
19,20-Epoxycytochalasin D (2)
18-Deoxy-19,20-epoxycytochalasin C (3)

Lettuce

Bentgrass

3
3
3

2
3
4

a

Concentration (mM) = 1 mg/mL. Ranking based on scale of 0 to 5; 0 = no effect; 5 = no growth;Solvent used, 10%
acetone; Concentration used, 1 mg/mL.

The in vitro cytotoxic potential of 1–3 was further evaluated against a panel of solid tumor cell
lines (SK-MEL, KB, BT-549, SK-OV-3) and kidney epithelial cells (LLC-PK11 ) (Table 4). Compounds 1
and 3 showed moderate toxicity to cell lines SK-MEL and BT-549, respectively, whereas compound 2
exhibited moderate toxicity to BT-549 and LLC-PK11 cell lines.
Table 4. Cytotoxic activity [IC50 (µM)] of 1–3.
Compound

SK-MEL

KB

BT-549

SK-OV-3

LLC-PK11

19,20-Epoxycytochalasin C (1)
19,20-Epoxycytochalasin D (2)
18-Deoxy-19,20-epoxycytochalasin C (3)
Doxorubicin a

8.02
NC
NC
1.29

NC
NC
NC
2.12

NC
7.84
6.89
1.83

NC
NC
NC
1.47

NC
8.4
NC
1.28

a

Positive control. NC: not cytotoxic at 10 µM. IC50 = concentration causing 50% growth inhibition. SK-MEL
= human malignant melanoma; KB = human epidermal carcinoma; BT-549 = human breast carcinoma (ductal);
SK-OV-3 = human ovary carcinoma; LLC-PK11 = pig kidney epithelial.

In vitro antiplasmodial [16,17] and antitoxoplasma [18] activities of cytochalasin derivatives
have been reported. These compounds have been shown [17,18] to inhibit the actin-based gliding
motility in extracellular parasites and impair erythrocyte invasion of apicomplexan parasites of
Toxoplasma gondii [18,31] and P. falciparum [32,33]. Both host cells and the parasites contain actin-based
cytoskeletons but due to their divergence, parasite actin-1 (PfACT-1) has been identified as a viable drug
target [33]. The information on the activity of this class of compound indicates that the observed potent
in vitro antimalarial activity with high selectivity indices for compounds 1 and 2 is most probably
due to their selective disruption of parasite actin-1 and not due to disruption of plant-like metabolic
pathways in apicoplasts. Even though in vitro antimalarial activity of this class of compounds has
previously been reported [16,17], their in vivo activity has not yet been reported. Cytochalasins B, D,
and E have been extensively studied for their anticancer effects. In animal models, no toxicity has been
observed at the therapeutic doses when administered in intraperitoneal, subcutaneous, or intravenous
injections up to 100 mg/kg/day [34–36].
Compound 1, which was isolated as the major compound, was evaluated for antimalarial activity
against P. berghei in mice at 100 mg/kg/day for 3 days through the oral route. Chloroquine was used
as the positive control. A control group of mice were treated with vehicle only. Three out of 5 animals
treated with compound 1 (Table 5) died due to drug induced toxicity. In animals that survived, 33.9%
and 71.4% suppression of parasitemia was observed on days 5 and 7, respectively (Table 5). Even
though compound 1 appears to have some suppressive activity at this dose, its high toxicity would
preclude it from being a viable antimalarial lead.
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Table 5. In vivo antimalarial activity of 1.
Treatment
(PO)

Dose (mg/kg × #
days Post Infection)

Vehicle
Chloroquine a
1

×3
100 × 3
100 × 3

% Parasitemia
Suppression b
Day 5
Day 7
100
33.9

100
71.4

Survival c

Day of Death

MST d

Cure f

0/5
5/5
0/5

14/14/13/13/5
28/28/28/28/28
17/5/3/1/0

11.8
28
5.2

0/5
2/5
0/2

a

Positive control; b % suppression in parasitemia is calculated by considering the mean parasitemia in the vehicle
control as 100%, Parasitemia suppression < 80% is considered as non-significant; c Number of animals that survived
day 28/total animals in group (the day of the death-post infection); d % MST—mean survival time (days); f Number
of mice without parasitemia (cured) till day 28 post-infection.

3. Materials and Methods
3.1. General Experimental Procedures
Optical rotations were measured using a Autopol IV automatic polarimeter model 589-546
(Rudolph Research Analytical, Flanders, NJ, USA). NMR spectra were recorded on a Bruker 400 MHz.
spectrometer (Rheinstetten, Germany) using CDCl3 /methanol-d4 as the solvent unless otherwise
stated. MS analyses were performed on an Agilent Series 1100 SL equipped with an ESI source
(Agilent Technologies, Palo Alto, CA, USA). Column chromatography was carried out on silica
gel 60 (230-400 mesh) (Sigma-Aldrich, St. Louis, MO, USA) and Sephadex LH-20 (GE Healthcare
Bio-Sciences, Marlborough, MA, USA). Preparative TLC was carried out using silica gel GF plates
(20 × 20 cm, thickness 0.25 mm). Spots were detected under UV light and by heating after spraying
with anisaldehyde reagent.
3.2. Fungal Material
Diseased leaves were collected from a cultivated T. taxifolia plant from Oxford, MS. A voucher
of the T. taxifolia Arn. plant was identified by E. M. Croom, Jr. and deposited in the University of
Mississippi Pullen Herbarium. The voucher accession number is MISS 83490. Leaves were surface
sterilized with 5% Chlorox for 5 min and rinsed with sterile water (×3). Transverse sections from the
dried leaf were cut aseptically into small portions and immersed in potato dextrose plates. The plates
were incubated for two weeks and fungal colonies were subcultured on PDA plates to isolate pure
fungal strains.
3.3. Fermentation, Extraction, and Purification
Fungus UM10M was cultured in four conical flasks (2 L) containing 500 mL of PDB and incubated
at 27 ◦ C for 30 days on an orbital shaker at 100 rpm. Mycelia and broth were separated by filtration and
extracted with EtOAc (×3). The organic layer from the broth was evaporated to give a brown/black
residue (625 mg).
This extract (600 mg) was chromatographed on Sephadex LH-20 and eluted with 80% MeOH in
CHCl3 to give 10 fractions. Fractions 2, 3, and 4 showed antimalarial activity. Fraction 2 was subjected
to silica gel gravity column chromatography using hexanes, CH2 Cl2 , and MeOH gradient as the mobile
phase to yield five fractions. Subfraction 3 which showed antimalarial activity was further separated
by preparative thin layer chromatography (PTLC) using 0.4% MeOH in CHCl3 (×3) as the developing
solvent to obtain 19,20-epoxycytochalasin C (1, 85.0 mg). Fractions 3 and 4 were also subjected to
PTLC using 0.4% MeOH in CHCl3 (×3) as the developing solvent to afford 19,20-epoxycytochalasin D
(2, 4 mg), and 18-deoxy-19,20-epoxycytochalasin C (3, 2 mg).
19,20-Epoxycytochalasin C (1); white amorphous powder; 1 H, 13 C NMR data (Table 1) [α]26
D −13 (c 0.5,
CHCl3 ) lit [24] −6.8; HRESIMS [M + H]+ m/z 524.2642.
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19,20-Epoxycytochalasin D (2); white amorphous powder; 1 H, and 13 C NMR, data were consistent with
+
literature values [30]. [α]26
D −113 (c 0.1, CHCl3 ) lit [34] −190; HRESIMS [M + H] m/z 524.2837.
18-Deoxy-19,20-epoxycytochalasin C (3); white amorphous powder; 1 H and 13 C NMR (see Table 1) [α]26
D
−2.4 (c 0.1, CHCl3 ); HRESIMS [M + H]+ m/z 508.2703 (calcd for [C24 H33 NO4 + H]+ 508.26201.
3.4. Biological Assays
3.4.1. In Vitro Antiplasmodial Assay
The antiplasmodial assay was performed against D6 (chloroquine sensitive) and W2 (chloroquine
resistant) strains of P. falciparum using the in vitro assay as reported [37]. Artemisinin and chloroquine
were included as the drug controls, and IC50 values were computed from the dose-response curves.
3.4.2. In Vitro Phytotoxicity Assay
Herbicidal or phytotoxic activity of the extract and compounds was performed according to the
published procedure [38] using bentgrass (Agrostis stolonifera) and lettuce (Lactuca sativa cv. L., Iceberg),
in 24-well plates. Phytotoxicity was ranked visually. The ranking of phytotoxic activity was based on a
scale of 0 to 5 with 0 showing no effect and 5 no growth.
3.4.3. In Vitro Cytotoxicity Assay
In vitro cytotoxicity was determined against a panel of mammalian cells that included kidney
fibroblast (Vero), kidney epithelial (LLC-PK11 ), malignant melanoma (SK-MEL), oral epidermal
carcinoma (KB), breast ductal carcinoma (BT-549), and ovary carcinoma (SK-OV-3) cells [39]
Doxorubicin was used as a positive control.
3.4.4. In Vivo Antimalarial Assay
The protocol for in vivo antimalarial evaluation was approved by the University of Mississippi
Institutional Animal Care and Use Committee (IACUC). The in vivo antimalarial activity was
determined in mice infected with P. berghei (NK-65 strain). Male mice (Swiss Webster strain) weighing
18-20 g were intraperitoneally inoculated with 2 × 107 parasitized red blood cells obtained from a
highly infected donor mouse. Mice were divided into different groups with five mice in each group.
Compound stocks were prepared in DMSO and administered orally to the mice through gavage
two hours after the infection (day 0). The animals were treated once daily for consecutive days
(day 0 to 2) and were closely observed for at least 2 h after every dose for any apparent signs of
toxicity. Blood smears were prepared on different days starting from 5 days post infection (through
28 days) by clipping the tail end, stained with Giemsa, and the slides were observed under microscope
for determination of parasitemia. Mice without parasitemia through day 28 postinfection were
considered as cured. Also, suppression in development of parasitemia was computed by comparing the
parasitemia in the control vehicle treated group and groups treated with compound. The mean survival
time was also computed for control and treated groups. The results are presented as parasitemia
suppression of day 5 post treatment, mean survival time of mice in each group, cure and survival
graphs computed by Prism 6.0. (San Diego, CA, USA).
3.5. DNA Analysis
A 0.5 by 1.5 cm piece of fungus grown on solid media was transferred into a 2 mL microcentrifuge
tube. Two 3 mm in diameter stainless steel balls were added and the sample ground for 1 min
in a MM2000 mixer mill (Retsch, Haan, Germany). DNA was extracted with the DNeasy Plant
mini kit (Qiagen, Valencia, CA, USA) according to the manufacturer’s recommendation. DNA was
eluted with 50 µL buffer AE. DNA quality and quantity was determined with the NanoDrop 1000
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Spectrophotometer (Thermo Fisher, Wilmington, DE, USA). DNA dilutions were prepared to achieve a
10 ng/µL solution to be used as template for PCR.
The internal transcribed spacer region (ITS) was amplified in a 25 µL reaction containing 10 ng
DNA, 1X PCR reaction buffer, 0.2 mM dNTP mixture, 0.2 µM of each forward and reverse primers
ITS1 and ITS4 [40], 1.5 mM MgSO4 and 1 U of Taq Polymerase High Fidelity (Invitrogen, Carlsbad,
CA, USA). The PCR program consisted of 40 cycles with denaturation at 94 ◦ C for 3 min, 50 ◦ C
annealing temperature for 30 s, 68 ◦ C for 90 s, and a final extension at 68 ◦ C for 3 min. After
amplification, an aliquot was analyzed by electrophoresis on a 0.7% TAE agarose gel. Successfully
amplified PCR products were cleaned up with MinElute PCR Purification Kit (Qiagen) according to
the manufacturer’s instructions. PCR products were cloned into pJet.1.2 blunt using the CloneJet PCR
cloning kit (Fermentas, Glen Burnie, MD, USA). Eight individual colonies were transferred into 4 mL
liquid LB carbenicillin media and grown under constant shaking overnight at 37 ◦ C. Plasmid DNA
from the overnight cultures was isolated with the Qiagen plasmid purification kit (Qiagen) according
to the manufacturer’s instructions. Sequencing was performed at the Genomics and Bioinformatics
Research Facility in Stoneville, MS. Resulting sequences were analyzed with DNASTAR (DNASTAR,
Madison, WI, USA). Homology searches were performed with the Basic Local Alignment Search Tool
(BLAST) [41]. The UM10M sequence was submitted to GenBank (Accession: MK321315).
To visualize sequence alignment the software Genedoc [42] was used. Shading is according
to alignment consensus as given by GeneDoc (black, 100%; dark grey, 80%; light grey, 60%)
(Supplementary, Figure S19). To identify close relatives of UM10M a phylogenetic analysis was
performed (Supplementary, Figure S19) using three best hits from the BLAST analysis and already
published sequences in Genebank of various taxa of the genus Nemania. The configuration for
the alignment analysis was maximum likelihood with the neighbor joining statistical method [43].
The percentage of replicate trees in which the associated taxa clustered together in the bootstrap
test (500 replicates) is shown next to the branches [44]. The evolutionary distances were computed
using the Kimura 2-parameter method [45] with nucleotide transitions and transversions included
and are in the units of the number of base substitutions per site. The analysis involved 42 nucleotide
sequences (Supplementary Table S1). All positions containing gaps and missing data were eliminated
by the software for the final dataset analysis. There were a total of 692 positions in the final dataset.
Evolutionary analyses were conducted in MEGA X [46].
4. Conclusions
Three cytochalasins were isolated from an endophytic fungus (UM10M) of the genus Nemania
identified from a diseased leaf of T. taxifolia Arnott. All compounds showed potent in vitro activity
against P. falciparum D6 and W2 strains with no cytotoxicity to Vero cells but displayed moderate to
weak cytotoxicity to some of the human solid tumor cell lines and kidney epithelial cells. Compound
1 was evaluated in a mouse model for activity against P. berghei at 100 mg/kg/day. It showed weak
suppressive activity but its high toxicity to animals would preclude it as a potential malaria drug lead.
Supplementary Materials: The following are available online. Figures S1–S18 are NMR spectra of compounds
1–3, Figure S19 is UM10M sequence alignment, Table S1 is Sequences used for alignment analysis and to identify
close relatives.
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